Trademark: 79229551
Word
RHEACELL
Status Date
Tuesday, March 12, 2019
Registration Number
5694020
Registration Date
Tuesday, March 12, 2019
Filing Date
Monday, February 5, 2018
Published for Opposition
Tuesday, December 25, 2018
5 Pharmaceutical and veterinary preparations for treatment of skin diseases; pharmaceutical and veterinary preparations for the treatment of vertigo; pharmaceutical and veterinary preparations for treatment of nausea; pharmaceutical and veterinary preparations for treatment of vomiting; pharmaceutical and veterinary preparations for treatment of migraine; pharmaceutical and veterinary preparations for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, the urinary system, the integumentary system, and the reproductive system; pharmaceutical and veterinary preparations for treatment of blood diseases and disorders; pharmaceutical and veterinary preparations, namely, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; pharmaceutical and veterinary preparations for wound healing; pharmaceutical and veterinary preparations for anti-aging, namely, stem cells for medical and aesthetic purposes, fibroblasts for medical and aesthetic purposes, surgical tissue implants obtained from stem cells, surgical tissue implants obtained from fibroblasts
42 Scientific and technological services, namely medical and scientific research services in the fields of regenerative medicine and tissue engineering, scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering, consulting services relating to scientific research in the fields of regenerative medicine and tissue engineering, providing information on medical and scientific research on pharmaceutical products, providing information in the form of expert reports relating to scientific research in the fields of regenerative medicine and tissue engineering; Industrial analysis, namely chemical analysis; research services, namely laboratory research services relating to pharmaceuticals, medical, biomedical and stem cell research in the field of regenerative medicine and tissue engineering, scientific and medical research and development for medical purposes in the field of regenerative medicine and tissue engineering, research and development services relating to new products for others, research in the field of biotechnology, research in the field of gene therapy, research and development in the field of immunology, research and development in the field of antibodies, research and development in the field of antibody technology, research and development in the field of bacteriology, research and development in the field of gene expression systems, research and development in the field of vaccines, pharmaceutical research and development services, research and development services in the field of biotechnology
The mark consists of the stylized word "RHEACELL" above a design consisting of two arrowheads making an "X" design.
Color is not claimed as a feature of the mark.
The wording "RHEACELL" has no meaning in a foreign language.
Mar 12, 2024
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jan 4, 2024
International Registration Renewed
Jul 19, 2019
Final Decision Transaction Processed By Ib
Jul 1, 2019
Final Disposition Notice Sent To Ib
Jul 1, 2019
Final Disposition Processed
Jun 12, 2019
Final Disposition Notice Created, To Be Sent To Ib
Mar 12, 2019
Registered-Principal Register
Dec 25, 2018
Official Gazette Publication Confirmation E-Mailed
Dec 25, 2018
Published For Opposition
Dec 5, 2018
Notification Of Notice Of Publication E-Mailed
Nov 13, 2018
Approved For Pub - Principal Register
Oct 24, 2018
Teas/Email Correspondence Entered
Oct 23, 2018
Correspondence Received In Law Office
Oct 23, 2018
Teas Request For Reconsideration Received
Oct 19, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 19, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 10, 2018
Final Refusal Mailed
Sep 10, 2018
Final Refusal Written
Aug 21, 2018
Teas/Email Correspondence Entered
Aug 21, 2018
Correspondence Received In Law Office
Aug 21, 2018
Assigned To Lie
Aug 1, 2018
Teas Response To Office Action Received
Jun 8, 2018
Refusal Processed By Ib
May 23, 2018
Non-Final Action Mailed - Refusal Sent To Ib
May 23, 2018
Refusal Processed By Mpu
May 19, 2018
Non-Final Action (Ib Refusal) Prepared For Review
May 18, 2018
Non-Final Action Written
May 17, 2018
Assigned To Examiner
Apr 4, 2018
Application Filing Receipt Mailed
Mar 31, 2018
New Application Office Supplied Data Entered
Mar 29, 2018
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
